Sumitomo Mitsui Trust Group’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,900
Closed -$492K 1082
2026
Q1
$492K Buy
13,900
+530
+4% +$16.4K ﹤0.01% 934
2025
Q4
$374K Buy
+13,370
New +$400K ﹤0.01% 991
2024
Q4
Sell
-11,400
Closed -$319K 1043
2024
Q3
$319K Sell
11,400
-1,600
-12% -$42.7K ﹤0.01% 1006
2024
Q2
$313K Buy
13,000
+4,500
+53% +$110K ﹤0.01% 1007
2024
Q1
$230K Sell
8,500
-1,500
-15% -$42.6K ﹤0.01% 1093
2023
Q4
$277K Hold
10,000
﹤0.01% 1090
2023
Q3
$280K Buy
+10,000
New +$293K ﹤0.01% 1094
2023
Q1
Sell
-16,075
Closed -$420K 1149
2022
Q4
$420K Buy
+16,075
New +$385K ﹤0.01% 1119

Other funds holding ALKS

Sumitomo Mitsui Trust Group's ALKS Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 13,900 shares — an estimated $492K sold.

Sumitomo Mitsui Trust Group first reported a position in ALKS in Q4 2022 and held it in 8 quarters. The position peaked at $492K in Q1 2026. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Sumitomo Mitsui Trust Group reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 13,900 Alkermes shares in Q2 2026, an estimated $492K.
  • Sumitomo Mitsui Trust Group first reported a position in Alkermes in Q4 2022 and held it in 8 quarters.
  • Sumitomo Mitsui Trust Group's Alkermes position peaked at $492K in Q1 2026.
  • 425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.